Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma

We evaluated the impact of achieving a rapid response in 840 newly diagnosed multiple myeloma patients from 2004 to 2015. Rates of very good partial response (VGPR) or better were 29% (240/840) after 2 cycles of treatment, 42% (350/840) after 4 cycles of treatment, and 66% (552/840) as best response...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Tandon, Nidhi, Sidana, Surbhi, Rajkumar, S. Vincent, Gertz, Morie A., Buadi, Francis K., Lacy, Martha Q., Kapoor, Prashant, Gonsalves, Wilson I., Dispenzieri, Angela, Kourelis, Taxiarchis V., Warsame, Rahma, Dingli, David, Fonder, Amie L., Hayman, Suzanne R., Hobbs, Miriam A., Hwa, Yi Lisa, Kyle, Robert A., Leung, Nelson, Go, Ronald S., Lust, John A., Russell, Stephen J., Kumar, Shaji K.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2019
Assuntos:
Lymphoid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6418495/
https://ncbi.nlm.nih.gov/pubmed/30824418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018022806
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados